Echelon Inc 제품 카탈로그
총 3,575개 제품 중 1,001–1,100번째 · 11 / 36 쪽. 파트넘버 순입니다. 제품을 열면 사양과 함께 재고·가격·납기를 문의할 수 있습니다.
- 850-17 25MG25 mg (850-17)
- 850-17 5MG5 mg (850-17)
- 855-10Furin Inhibitor II (Hexa-D-Arginine)
- 855-10 1MG1 mg (855-10)
- 855-10 25MG25 mg (855-10)
- 855-10 5MG5 mg (855-10)
- 855-18D-Ile-Pro-Arg-AMC
- 855-18 25MG25 mg (855-18)
- 855-18 5MG5 mg (855-18)
- 855-19D-Ile-Pro-Arg-pNA
- 855-19 25MG25 mg (855-19)
- 855-19 5MG5 mg (855-19)
- 855-31D-Val-Gly-Arg-pNA
- 855-31 10MG10 mg (855-31)
- 855-31 25MG25 mg (855-31)
- 855-44D-Val-Lys-Lys-Arg-AMC
- 855-44 10MG10 mg (855-44)
- 855-44 25MG25 mg (855-44)
- 855-46Abz-Ala-Gly-Leu-Ala-p-nitrobenzylamide (Metalloendopeptidase Substrate)
- 855-46 10MG10 mg (855-46)
- 855-46 25MG25 mg (855-46)
- 855-71Ac-Arg-Ala-Arg-AMC
- 855-71 5MG5 mg (855-71)
- 860-11Ac-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate)
- 860-11 25MG25 mg (860-11)
- 860-11 5MG5 mg (860-11)
- 860-12Ac-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate)
- 860-12 25MG25 mg (860-12)
- 860-12 5MG5 mg (860-12)
- 860-15Ac-Tyr-Val-Ala-Asp-pNA (Caspase 1 (ICE) Substrate)
- 860-15 25MG25 mg (860-15)
- 860-15 5MG5 mg (860-15)
- 860-16Ac-Tyr-Val-Ala-Asp-AMC (Caspase 1 (ICE) Substrate)
- 860-16 25MG25 mg (860-16)
- 860-16 5MG5 mg (860-16)
- 860-17Ac-Tyr-Val-Ala-Asp-AFC (Caspase 1 (ICE) Substrate)
- 860-17 25MG25 mg (860-17)
- 860-17 5MG5 mg (860-17)
- 860-18Ac-Asp-Glu-Val-Asp-AMC (Caspase 3 (Apopain) Substrate)
- 860-18 25MG25 mg (860-18)
- 860-18 5MG5 mg (860-18)
- 860-20Ac-Asp-Glu-Val-Asp-pNA (Caspase-3 (Apopain) Substrate)
- 860-20 25MG25 mg (860-20)
- 860-20 5MG5 mg (860-20)
- 860-25Ac-Asp-Met-Gln-Asp-pNA (Caspase 3 (Apopain) Substrate)
- 860-25 25MG25 mg (860-25)
- 860-25 5MG5 mg (860-25)
- 860-26Ac-Val-Glu-Thr-Asp-AMC (Caspase 8 Substrate)
- 860-26 25MG25 mg (860-26)
- 860-26 5MG5 mg (860-26)
- 860-28Ac-Asp-Met-Gln-Asp-AMC (Caspase 3 (Apopain) Substrate)
- 860-28 25MG25 mg (860-28)
- 860-28 5MG5 mg (860-28)
- 860-30Ac-Asp-Met-Gln-Asp-AFC (Caspase 3 Substrate)
- 860-30 5MG5 mg (860-30)
- 860-41Ac-Tyr-Glu-Val-Asp-AMC (Caspase 1 (ICE) Substrate)
- 860-41 25MG25 mg (860-41)
- 860-41 5MG5 mg (860-41)
- 860-42Ac-Leu-Glu-Val-Asp-pNA (Caspase 4 (ICH-2) Substrate)
- 860-42 25MG25 mg (860-42)
- 860-42 5MG5 mg (860-42)
- 860-43Ac-Leu-Asp-Glu-Ser-Asp-AMC (Caspase 2/3 Substrate)
- 860-43 25MG25 mg (860-43)
- 860-43 5MG5 mg (860-43)
- 860-44Ac-Val-Asp-Gln-Gln-Asp-pNA (Caspase 2 (ICH-1) Substrate)
- 860-44 25MG25 mg (860-44)
- 860-44 5MG5 mg (860-44)
- 860-45Ac-Leu-Glu-His-Asp-AMC (Caspase 9 Substrate)
- 860-45 25MG25 mg (860-45)
- 860-45 5MG5 mg (860-45)
- 860-46Ac-Val-Asp-Val-Ala-Asp-pNA (Caspase 2 (ICH-1) Substrate)
- 860-46 25MG25 mg (860-46)
- 860-46 5MG5 mg (860-46)
- 860-47Ac-Leu-Glu-His-Asp-pNA (Caspase 9 Substrate)
- 860-47 25MG25 mg (860-47)
- 860-47 5MG5 mg (860-47)
- 860-48Ac-Val-Asp-Val-Ala-Asp-AMC (Caspase 2 (ICH-1) Substrate)
- 860-48 25MG25 mg (860-48)
- 860-48 5MG5 mg (860-48)
- 860-49Ac-Leu-Glu-Val-Asp-AMC (Caspase 4 Substrate)
- 860-49 25MG25 mg (860-49)
- 860-49 5MG5 mg (860-49)
- 860-50Ac-Val-Glu-Ile-Asp-pNA (Caspase 6 (Mch2) Substrate)
- 860-50 25MG25 mg (860-50)
- 860-50 5MG5 mg (860-50)
- 860-52Ac-Val-Glu-Ile-Asp-AMC (Caspase 6 (Mch2) Substrate)
- 860-52 25MG25 mg (860-52)
- 860-52 5MG5 mg (860-52)
- 860-54Ac-Val-Gln-Val-Asp-pNA (Caspase 3 Substrate)
- 860-54 25MG25 mg (860-54)
- 860-54 5MG5 mg (860-54)
- 860-56Ac-Ile-Glu-Thr-Asp-pNA (Caspase 8 Substrate)
- 860-56 25MG25 mg (860-56)
- 860-56 5MG5 mg (860-56)
- 860-57Ac-Val-Glu-Ile-Asp-CHO (Caspase 6 (Mch2) Inhibitor)
- 860-57 5MG5 mg (860-57)
- 860-58Ac-Ile-Glu-Thr-Asp-AMC (Caspase 8/Granzyme B Substrate)
- 860-58 25MG25 mg (860-58)
- 860-58 5MG5 mg (860-58)
- 860-59Ac-Ile-Glu-Thr-Asp-CHO (Caspase 8 Inhibitor / Granzyme B Inhibitor II)